Triptolide inhibits proliferation and invasion of malignant glioma cells.

Journal of Neuro-oncology
Haipeng ZhangJingXia Zhang

Abstract

Malignant glioma is the most devastating and aggressive tumor in brain, characterized by rapid proliferation and diffuse invasion. Chemotherapy and radiotherapy are the pivotal strategies after surgery; however, high drug resistance of malignant glioma and the blood-brain barrier usually render chemotherapy drugs ineffective. Here, we find that triptolide, a small molecule with high lipid solubility, is capable of inhibiting proliferation and invasion of malignant glioma cells effectively. In both investigated malignant glioma cell lines, triptolide repressed cell proliferation via inducing cell cycle arrest in G0/G1 phase, associated with downregulation of G0/G1 cell cycle regulators cyclin D1, CDK4, and CDK6 followed by reduced phosphorylation of retinoblastoma protein (Rb). In addition, triptolide induced morphological change of C6 cells through downregulation of protein expression of MAP-2 and inhibition of activities of GTPases Cdc42 and Rac1/2/3, thus significantly suppressing migratory and invasive capacity. Moreover, in an in vivo tumor model, triptolide delayed growth of malignant glioma xenografts. These findings suggest an important inhibitory action of triptolide on proliferation and invasion of malignant glioma, an...Continue Reading

References

Jan 1, 1973·Annual Review of Biochemistry·J B Olmsted, G G Borisy
Feb 7, 1998·Science·A Hall
May 18, 1999·Current Opinion in Oncology·B K RasheedD D Bigner
Jun 7, 2000·Proceedings of the National Academy of Sciences of the United States of America·E C Holland
Jun 29, 2000·Annual Review of Biochemistry·K KaibuchiM Amano
Oct 29, 2000·The Journal of Biological Chemistry·W T ChangG D Rosen
Nov 18, 2000·Experimental Cell Research·A A SchmitzL Van Aelst
Jan 11, 2001·The New England Journal of Medicine·L M DeAngelis
Apr 3, 2001·Annual Review of Neuroscience·R Wechsler-Reya, M P Scott
Apr 23, 2003·Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]·Rolf-Dieter KortmannMichael Bamberg
Apr 2, 2004·Nature Reviews. Cancer·Mary Ann Jordan, Leslie Wilson
Mar 11, 2005·The New England Journal of Medicine·Roger StuppUNKNOWN National Cancer Institute of Canada Clinical Trials Group
Nov 9, 2005·Expert Review of Neurotherapeutics·M Kelly NicholasSamir Bangalore
Jun 17, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Tarikere L GururajaDonald G Payan
Aug 26, 2006·Nature Clinical Practice. Neurology·Warren P Mason, J Gregory Cairncross
Jan 30, 2007·Cellular and Molecular Life Sciences : CMLS·M NakadaM E Berens
Aug 8, 2007·Proceedings of the National Academy of Sciences of the United States of America·Yan LiGuangmei Yan
Aug 19, 2007·The Journal of International Medical Research·J LinM Zhao
Sep 29, 2007·The Journal of International Medical Research·J LinM-L Zhao
May 13, 2011·Current Drug Targets·Somesh Baranwal, Suresh K Alahari

❮ Previous
Next ❯

Citations

Dec 24, 2019·Bioscience Trends·Jinjing WangLin Zhao
Apr 22, 2015·Laboratory Investigation; a Journal of Technical Methods and Pathology·Amanda OliveiraVikas Dudeja
May 17, 2018·International Journal of Molecular Medicine·Linna ZhangQikuan Hu
Nov 2, 2013·Asian Pacific Journal of Cancer Prevention : APJCP·Yao Liu, Yun-Fu Cui
Aug 13, 2017·The Biochemical Journal·Matthias DedobbeleerBernard Rogister
Dec 9, 2020·Journal of Controlled Release : Official Journal of the Controlled Release Society·Kevin LiawRangaramanujam M Kannan
Aug 2, 2021·Cellular and Molecular Life Sciences : CMLS·Mariana MedeirosMaría Sol Brassesco

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.

Blood Brain Barrier Regulation in Health & Disease

The blood brain barrier is essential in regulating the movement of molecules and substances in and out of the brain. Disruption to the blood brain barrier and changes in permeability allow pathogens and inflammatory molecules to cross the barrier and may play a part in the pathogenesis of neurodegenerative disorders. Here is the latest research in this field.

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.

Cell Cycle Pathways

Cell cycle is a complex process regulated by several signal transduction pathways and enzymes. Here is the latest research on regulation of cell cycle and cell cycle pathways.